We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Diurnal Group Plc | LSE:DNL | London | Ordinary Share | GB00BDB6Q760 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.30 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDNL
RNS Number : 3933U
Diurnal Group PLC
17 January 2017
17 January 2017
Diurnal Group plc
("Diurnal" or the "Company")
Director Dealings
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, received notification of the following purchase of shares by a person closely associated to a Company Director on 16 January 2017:
Mrs Lynne Raymond, wife of Alan Raymond, Non-executive Director, purchased 9,000 ordinary shares of 5.0 pence each in the Company ("Ordinary Shares") at a price of 110 pence per Ordinary Share. Following the transaction, Alan Raymond and his connected parties have a total interest of 22,888 Ordinary Shares, representing 0.04% of the total voting rights.
For further information, please visit www.diurnal.co.uk or contact: +44 (0)20 3727 Diurnal Group plc 1000 Martin Whitaker, CEO Richard Bungay, CFO Numis Securities Ltd (Nominated +44 (0)20 7260 Adviser) 1000 Nominated Adviser: Michael Meade, Freddie Barnfield, Paul Gillam Corporate Broking: James Black +44 (0)20 3727 FTI Consulting 1000 Simon Conway Victoria Foster Mitchell
Notes to Editors
About Diurnal Group plc
Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.
For further information about Diurnal, please visit www.diurnal.co.uk
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
Details of the person discharging managerial responsibilities/person closely associated --- -------------------------------------------------------------- a) Name: Lynne Ryamond --- --------------------------------- --------------------------- Reason for the notification --- -------------------------------------------------------------- a) Position/status: Closely associated person to a Non-Executive Director --- --------------------------------- --------------------------- b) Initial notification/Amendment: Initial --- --------------------------------- --------------------------- Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- -------------------------------------------------------------- a) Name: Diurnal Group plc --- --------------------------------- --------------------------- b) LEI: n/a --- --------------------------------- --------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- -------------------------------------------------------------- a) Description of the financial Ordinary shares of instrument, type of instrument: 5p each. Identification code: GB00BDB6Q760 --- --------------------------------- --------------------------- b) Nature of the transaction: Purchase --- --------------------------------- --------------------------- c) Price(s) and volume(s): Price(s) Volume(s) --------- ---------- 110p 9,000 --------- ---------- --- --------------------------------- --------------------------- d) Aggregated information: Aggregated volume: 9,000 Price: GBP9,900.00 --- --------------------------------- --------------------------- e) Date of the transaction: 16 January 2017 --- --------------------------------- --------------------------- f) Place of the transaction: XLON --- --------------------------------- ---------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFFELTIDLID
(END) Dow Jones Newswires
January 17, 2017 10:30 ET (15:30 GMT)
1 Year Diurnal Chart |
1 Month Diurnal Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions